Cera, Europe’s largest provider of digital-first home healthcare, has raised £122m ($150m) to fuel its AI-driven growth plans.
The round was led by funds affiliated with BDT & MSD Partners and Schroders Capital in order to scale Cera’s platform.
The company says this is highly AI-driven, with proprietary modelling based on its own data.
CEO and co-founder Dr Ben Maruthappu said: “This comes at an important time, as health and care systems face unprecedented challenges, and a NHS hospitals nationwide experience tremendous pressures.
“I’ve always been motivated by the belief that Tech companies have a huge role to play in making healthcare more sustainable, and this news feels even more meaningful as it will enable us to better support the NHS at a critical time.
“We’re very grateful to BDT and MSD Partners and Schroders Capital for leading this funding round: it’s fantastic to have such strong partners join us as we move into our next chapter.
“Thanks also to all our partners and existing investors for their ongoing support.”
Europe’s largest provider of digital-first home healthcare secures £260m to fuel investment
Cera is transforming healthcare by moving services such as care, nursing, telehealth and repeat medications out of hospitals and into people’s own homes through technology.
Launched in November 2016, Cera has grown from scratch to a team of almost 10,000 professionals, providing over 60,000+ in-person healthcare visits in homes throughout the UK every day.
This journey began when Dr Maruthappu experienced first-hand problems in the healthcare sector whilst trying to organise care for a loved one.
In 2022 Cera raised £260min an equity and debt financing round.